Technology · Bioproduction & equipment / Upstream & bioreactors

Continuous biopharma manufacturing & next-generation facilities

Feeding inputs in and removing outputs continuously instead of batch, moving from stainless steel to single-use bioreactors — at commercial scale (Genentech, Biogen) with reported facility-cost savings of 30–50 % and ICH Q13 as the common guidance.

Maturity 8/9 Risk: medium Biomanufacturing & Bio-industrial Production Pharma & biologics US · EU verified 2026-10-16 · 5 Sources

1 · What it gives

Continuous manufacturing feeds input materials continuously and removes output at the same time, in contrast to traditional batch processing; next-generation integrated processes are shifting from stainless steel to single-use bioreactors. It has reached commercial scale, for example Genentech’s South San Francisco facility and Biogen’s Denmark facility, and can cut facility cost by 30–50 % against batch. Amgen, Pfizer and MSD take part in the NIIMBL design consortia.

2 · What it replaces 6

D1	Fermentation (stainless and single-use bioreactors, solid-state reactors) and downstream equipment (centrifuges, filtration, spray and fluid-bed drying, formulation) for local production of enzymes, microbial products and fermentation ingredients instead of chemical-synthesis plants and imports Replaces: Chemical-synthesis routes and imports for the products in FI-, FD-, I- and A-series articles (enzymes, organic acids, vitamins, microbial …	EAC
D1	Acid mine drainage and metal-rich mine water treatment with passive biological systems — sulfate-reducing bioreactors, compost wetlands, aerobic wetlands — instead of perpetual lime dosing Replaces: Active chemical treatment with lime/caustic soda (high-volume metal hydroxide sludge, continuous chemical and energy use), or no treatment …	SERV
D1	Farm nitrate and phosphate runoff controlled by biology — denitrifying bioreactors, wetlands and algal uptake — instead of end-of-pipe chemical dosing Replaces: End-of-pipe chemical treatment of nutrient-rich drainage (ferric/alum P-stripping, ion exchange); untreated tile-drain nitrate; part of …	SERV
D0	Oilfield produced water treated biologically instead of chemical-only conditioning and disposal Replaces: Continuous chemical conditioning of produced water (biocides, scale inhibitors, emulsion breakers, demulsifiers) ahead of …	SERV
D1	Plant-based meat and dairy analogues and cultivated (cell-cultured) meat and seafood instead of a share of conventional meat and its antibiotic, antiparasitic and feed-chain chemical inputs Replaces: A share of conventional meat, seafood and dairy — and the antibiotics, antiparasitics, feed-crop pesticides and fertilizer of the animal …	NOVEL
D2	Poultry coccidiosis control with live Eimeria vaccines (and phytogenic support) instead of continuous in-feed ionophores and chemical coccidiostats Replaces: Ionophore coccidiostats (monensin, salinomycin, narasin, lasalocid, maduramicin, semduramicin) and chemical anticoccidials (nicarbazin, …	VET

3 · How to implement 3 steps

1
Engineering
Run the engineering stage of the new facility.
2
Test
Carry out factory and site acceptance testing (FAT/SAT).
3
Validate
Validate the process and facility.

4 · Who delivers

Matched suppliers (matched automatically)

PBS Biotech	United States	Services / consulting	active
True Eco Sdn Bhd	Malaysia	Distributor	active
Boehringer Ingelheim	Germany	Producer	active
BIONET	Spain	Services / consulting	active
BM GreenTech Berhad	Malaysia	Research / RTO	active
CABI	United Kingdom	Research / RTO	active
Lombricorp S.A.	Ecuador	Services / consulting	active
Papop	Thailand	Services / consulting	active
Pyrogreen Energy	China	Producer	active
YASCAI AND FAMILY PLC	Ethiopia	Producer	active
AGC Biologics	United States	Producer	active
Amgen	United States	Producer	active

Leading companies and institutes (from the brief)

Amgen, Pfizer and Merck Sharp & Dohme participate in the NIIMBL next-generation manufacturing consortia. Others are matched by the portal under Biomanufacturing and Pharma & biologics.

5 · Rules & route to market

Route into Russia / EAEU: EAC · EAEU accredited bodies / Rosakkreditatsiya
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)

United States

ICH Q13 provides the common framework for continuous manufacturing across regions, including the FDA, EMA and PMDA.

European Union

ICH Q13 provides the common framework for continuous manufacturing in the EU through the EMA, among other regions.

China

The sources reviewed on 2026-10-16 identified no China regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.

6 · Money: tenders & grants

Grant	Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not … National Institutes of Health · United States	Jan 25, 2028 466 days
Grant	Fostering common farmland birds and mammals for resilient food production systems European Commission · EU	Sep 22, 2027 341 days
Grant	Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU	Apr 8, 2027 174 days
Grant	Technical innovation to protect ecosystems and to scale up their restoration European Commission · EU	Sep 22, 2027 341 days
Grant	Textile circularity through advanced processing and manufacturing technologies and system approaches (IA) … European Commission · EU	Feb 2, 2027 109 days

7 · Tech stack & innovations

Main risks from the sources: regulatory challenges and uncertainty about recovering capital investment.

Sources 5

Mdpi.com — www.mdpi.com 2026-10-16
Dechema.de — dechema.de 2026-10-16
Nationalacademies.org — www.nationalacademies.org 2026-10-16
Niimbl.org — www.niimbl.org 2026-10-16
Biotech.senate.gov — www.biotech.senate.gov 2026-10-16